Home

ALEXANDRA DIANE JANET MANCINI

CIK 1817890 · Sr VP, Clinical Reg Affairs · last filed 2024-08-02

ALEXANDRA DIANE JANET MANCINI is a Sr VP, Clinical Reg Affairs who has filed 14 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing shows the insider sold $42 of INM on Aug 2, 2024. Across all open-market trades the lifetime net is −$42, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

14

Lifetime Open-Market Net

-$42

Filer Profile

Reported Address
C/O INMED PHARMACEUTICALS INC.
SUITE 310 - 815 HASTINGS STREET
VANCOUVER, A1 V6C 1B4
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INM Sr VP, Clinical Reg Affairs 0 $1.29 $0 -$42 14 2024-08-02

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-08-02 INM Sell (S) −240 -$42 EDGAR
2024-05-28 INM H — $0 EDGAR
2024-03-05 INM H — $0 EDGAR
2023-12-26 INM Grant (A) — $0 EDGAR
2023-05-16 INM H — $0 EDGAR
2023-03-09 INM H — $0 EDGAR
2022-12-19 INM Grant (A) — $0 EDGAR
2022-11-18 INM Disp (D) — $0 EDGAR
2022-11-15 INM Grant (A) — $0 EDGAR
2022-06-02 INM H — $0 EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.